← All Startups
XyloCor Therapeutics Series B
Gene therapy for cardiovascular diseases
XyloCor Therapeutics is a biopharmaceutical company intended to develop gene therapy for people with coronary artery disease.
Location
King Of Prussia, PA
Stage
Series B
Website
xylocor.com
LinkedIn
View profile
BiotechnologyHealth CarePharmaceutical
Founders
R
Ronald Crystal, Professor
LinkedIn
News & Funding
2025-01-07 Series B Read article
Similar Startups
Centivax
Broad-spectrum vaccine
Stephanie Wisner ’16, ,
Patientory
Web3 for health data
Chrissa McFarlane ’11, ,
Latent Series A
Medical language models for healthcare overhead
Rishabh Jain ’17, ,
SimpliFed Series A
Baby breastfeeding virtual care
Andrea Ippolito ’06, MEng ’07, ,
ModMed
Software for specialty medical practices
Daniel Cane ’98, ,
Obsidian Therapeutics Series C
Cell and gene therapies
Vic Myer ’89, Jeffrey Trigilio ’06,